Clinical and laboratory-induced colistin-resistance mechanisms in Acinetobacter baumannii

The increasing incidence and emergence of multi-drug resistant (MDR) Acinetobacter baumannii has become a major global health concern. Colistin is a historic antimicrobial that has become commonly used as a treatment for MDR A. baumannii infections. The increase in colistin usage has been mirrored by an increase in colistin resistance. We aimed to identify the mechanisms associated with colistin resistance in A. baumannii using multiple high-throughput-sequencing technologies, including transposon-directed insertion site sequencing (TraDIS), RNA sequencing (RNAseq) and whole-genome sequencing (WGS) to investigate the genotypic changes of colistin resistance in A. baumannii. Using TraDIS, we found that genes involved in drug efflux (adeIJK), and phospholipid (mlaC, mlaF and mlaD) and lipooligosaccharide synthesis (lpxC and lpsO) were required for survival in sub-inhibitory concentrations of colistin. Transcriptomic (RNAseq) analysis revealed that expression of genes encoding efflux proteins (adeI, adeC, emrB, mexB and macAB) was enhanced in in vitro generated colistin-resistant strains. WGS of these organisms identified disruptions in genes involved in lipid A (lpxC) and phospholipid synthesis (mlaA), and in the baeS/R two-component system (TCS). We additionally found that mutations in the pmrB TCS genes were the primary colistin-resistance-associated mechanisms in three Vietnamese clinical colistin-resistant A. baumannii strains. Our results outline the entire range of mechanisms employed in A. baumannii for resistance against colistin, including drug extrusion and the loss of lipid A moieties by gene disruption or modification.

[1]  Amy K. Cain,et al.  Morphological, genomic and transcriptomic responses of Klebsiella pneumoniae to the last-line antibiotic colistin , 2018, Scientific Reports.

[2]  James Hadfield,et al.  Phandango: an interactive viewer for bacterial population genomics , 2017, bioRxiv.

[3]  Amy K. Cain,et al.  The secondary resistome of multidrug-resistant Klebsiella pneumoniae , 2017, Scientific Reports.

[4]  Ming-Feng Lin,et al.  Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii , 2017, Journal of Microbiology.

[5]  Amy K. Cain,et al.  Fluorescence-Based Flow Sorting in Parallel with Transposon Insertion Site Sequencing Identifies Multidrug Efflux Systems in Acinetobacter baumannii , 2016, mBio.

[6]  S. Baker,et al.  The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications , 2016, Scientific Reports.

[7]  Brian T. Tsuji,et al.  Polymyxin Resistance in Acinetobacter baumannii: Genetic Mutations and Transcriptomic Changes in Response to Clinically Relevant Dosage Regimens , 2016, Scientific Reports.

[8]  T. Read,et al.  Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae , 2016, Nature Microbiology.

[9]  You-ning Liu,et al.  Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria , 2016, Antimicrobial Agents and Chemotherapy.

[10]  Mark B. Schultz,et al.  Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward , 2016, Microbial genomics.

[11]  Andrew J. Page,et al.  The TraDIS toolkit: sequencing and analysis for dense transposon mutant libraries , 2016, Bioinform..

[12]  Yu Chen,et al.  Meta-analysis of colistin for the treatment of Acinetobacter baumannii infection , 2015, Scientific Reports.

[13]  K. Holt,et al.  Multiple Genetic Mutations Associated with Polymyxin Resistance in Acinetobacter baumannii , 2015, Antimicrobial Agents and Chemotherapy.

[14]  David J. Edwards,et al.  ISMapper: identifying transposase insertion sites in bacterial genomes from short read sequence data , 2015, BMC Genomics.

[15]  Ming-Feng Lin,et al.  The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii , 2015, PloS one.

[16]  Christine J. Boinett,et al.  Complete Genome Sequence of Bordetella pertussis D420 , 2015, Genome Announcements.

[17]  J. Boyce,et al.  The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model. , 2015, The Journal of antimicrobial chemotherapy.

[18]  Lars Barquist,et al.  High-Throughput Analysis of Gene Essentiality and Sporulation in Clostridium difficile , 2015, mBio.

[19]  R. Isberg,et al.  Antibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii , 2015, PLoS pathogens.

[20]  Jacqueline A. Keane,et al.  Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins , 2014, Nucleic acids research.

[21]  N. P. H. Lan,et al.  Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam , 2014, Journal of medical microbiology.

[22]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[23]  N. Thomson,et al.  RNA-seq analysis of the influence of anaerobiosis and FNR on Shigella flexneri , 2014, BMC Genomics.

[24]  J. Boyce,et al.  Biological Cost of Different Mechanisms of Colistin Resistance and Their Impact on Virulence in Acinetobacter baumannii , 2013, Antimicrobial Agents and Chemotherapy.

[25]  J. Segre,et al.  Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment , 2013, Genome research.

[26]  Lars Barquist,et al.  Approaches to querying bacterial genomes with transposon-insertion sequencing , 2013, RNA biology.

[27]  R. Hall,et al.  Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes , 2013, PloS one.

[28]  Eric P. Skaar,et al.  Genetic Determinants of Intrinsic Colistin Tolerance in Acinetobacter baumannii , 2012, Infection and Immunity.

[29]  R. Bender,et al.  Regulation of the Histidine Utilization (Hut) System in Bacteria , 2012, Microbiology and Molecular Reviews.

[30]  Rui Wang,et al.  Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. , 2012, The Journal of antimicrobial chemotherapy.

[31]  P. Courvalin,et al.  Expression of the Resistance-Nodulation-Cell Division Pump AdeIJK in Acinetobacter baumannii Is Regulated by AdeN, a TetR-Type Regulator , 2012, Antimicrobial Agents and Chemotherapy.

[32]  Michael A Quail,et al.  Optimal enzymes for amplifying sequencing libraries , 2011, Nature Methods.

[33]  Jungmin Kim,et al.  Complete Genome Sequence of Multidrug-Resistant Acinetobacter baumannii Strain 1656-2, Which Forms Sturdy Biofilm , 2011, Journal of bacteriology.

[34]  J. Boyce,et al.  Colistin-Resistant, Lipopolysaccharide-Deficient Acinetobacter baumannii Responds to Lipopolysaccharide Loss through Increased Expression of Genes Involved in the Synthesis and Transport of Lipoproteins, Phospholipids, and Poly-β-1,6-N-Acetylglucosamine , 2011, Antimicrobial Agents and Chemotherapy.

[35]  Evan S Snitkin,et al.  Genome-wide recombination drives diversification of epidemic strains of Acinetobacter baumannii , 2011, Proceedings of the National Academy of Sciences.

[36]  R. Hancock,et al.  The pmrCAB Operon Mediates Polymyxin Resistance in Acinetobacter baumannii ATCC 17978 and Clinical Isolates through Phosphoethanolamine Modification of Lipid A , 2011, Antimicrobial Agents and Chemotherapy.

[37]  J. Boyce,et al.  Insertion Sequence ISAba11 Is Involved in Colistin Resistance and Loss of Lipopolysaccharide in Acinetobacter baumannii , 2011, Antimicrobial Agents and Chemotherapy.

[38]  María-Eugenia Guazzaroni,et al.  Bacterial sensor kinases: diversity in the recognition of environmental signals. , 2010, Annual review of microbiology.

[39]  Jian Li,et al.  Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production , 2010, Antimicrobial Agents and Chemotherapy.

[40]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[41]  Julian Parkhill,et al.  Evolution of MRSA During Hospital Transmission and Intercontinental Spread , 2010, Science.

[42]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[43]  Leopold Parts,et al.  Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. , 2009, Genome research.

[44]  P. Sokol,et al.  Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. , 2009, Microbiology.

[45]  M. Adams,et al.  Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System , 2009, Antimicrobial Agents and Chemotherapy.

[46]  T. Silhavy,et al.  An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane , 2009, Proceedings of the National Academy of Sciences.

[47]  R. Nation,et al.  Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  R. Bonomo,et al.  Global Challenge of Multidrug-Resistant Acinetobacter baumannii , 2007, Antimicrobial Agents and Chemotherapy.

[49]  Alexandros Stamatakis,et al.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models , 2006, Bioinform..

[50]  L. Piddock.  Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria , 2006, Clinical Microbiology Reviews.

[51]  E. Nicastri,et al.  Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[52]  Raquel Tobes,et al.  The TetR Family of Transcriptional Repressors , 2005, Microbiology and Molecular Biology Reviews.

[53]  Matthew E Falagas,et al.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  E. Groisman,et al.  The PmrA-Regulated pmrC Gene Mediates Phosphoethanolamine Modification of Lipid A and Polymyxin Resistance in Salmonella enterica , 2004, Journal of bacteriology.

[55]  J. Helmann,et al.  The Bacillus subtilis Extracytoplasmic-Function σX Factor Regulates Modification of the Cell Envelope and Resistance to Cationic Antimicrobial Peptides , 2004, Journal of bacteriology.

[56]  J. Garnacho-Montero,et al.  Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  T. Raivio,et al.  A third envelope stress signal transduction pathway in Escherichia coli , 2002, Molecular microbiology.

[58]  A. Yamaguchi,et al.  The Putative Response Regulator BaeR Stimulates Multidrug Resistance of Escherichia coli via a Novel Multidrug Exporter System, MdtABC , 2002, Journal of bacteriology.

[59]  J. Andrews,et al.  Determination of minimum inhibitory concentrations. , 2001, The Journal of antimicrobial chemotherapy.

[60]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[61]  N. Grishin,et al.  The Zn-peptidase superfamily: functional convergence after evolutionary divergence. , 1999, Journal of molecular biology.

[62]  M. Sarvas,et al.  Decreased binding of polymyxin by polymyxin-resistant mutants of Salmonella typhimurium , 1979, Journal of bacteriology.